TrialRheumatology (Oxford, England)2026

A randomised open-label pilot trial comparing mycophenolate mofetil with no immunosuppression in limited cutaneous systemic sclerosis (MINIMISE-Pilot).

Christopher P Denton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.